Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extension Trial to Study the Long-term Safety and Efficacy in Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in Gotistobart Trials

NCT07659379 is registered in ClinicalTrials.gov with OncoC4, Inc. as lead sponsor.

NCT NCT07659379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07659379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extension Trial to Study the Long-term Safety and Efficacy in Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in Gotistobart Trials
Lead sponsor
OncoC4, Inc.
Phase
Phase 3
Overall status
Enrolling by invitation
Start date
July 28, 2026
Completion date
January 1, 2037
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor